REPORT HIGHLIGHT
Lentiviral Vector Contract Development and Manufacturing Organizations Market size was valued at USD 152.2 Million in 2022, expanding at a CAGR of 6.2% from 2023 to 2030.
Contract Development and Manufacturing Organizations (CDMOs) are specialized in lentiviral vector production. These organizations offer services for the development, manufacturing, and production of lentiviral vectors for gene therapy, cell therapy, and other Disease Indications.
Lentiviral Vector Contract Development and Manufacturing Organizations Market- Market Dynamics:
Growing emphasis on cell and gene therapies is expected to propel the Lentiviral Vector Contract Development and Manufacturing Organizations demand.
Numerous hereditary and acquired diseases, such as cancer, rare genetic abnormalities, and autoimmune diseases, have showed great promise in the treatment with gene and cell treatments. The need for lentiviral vectors, which are essential resources for delivering therapeutic genes to target cells, is anticipated to rise as more possible therapeutic targets are discovered and verified. Ex vivo gene editing and modified cell treatments are just a couple of the therapeutic uses for lentiviral vectors' adaptability and versatility. The investigation of novel therapeutic modalities and individualized medical strategies has increased demand for CDMOs using lentiviral vectors.
Further, the development of gene and cell therapies has received support from regulatory organizations like the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA). The need for trustworthy lentiviral vector manufacturing partners has increased because of the quicker regulatory procedures and other incentives they have offered to support the research and marketing of these novel medicines.
Lentiviral Vector Contract Development and Manufacturing Organizations Market- Key Insights:
- As per the analysis shared by our research analyst, the global Lentiviral Vector Contract Development and Manufacturing Organizations market is estimated to grow annually at a CAGR of around 6.2% over the forecast period (2023-2030)
- The Lentiviral Vector Contract Development and Manufacturing Organizations industry is projected to grow at a significant rate due to the growing focus on manufacturing industries.
- Based on Disease Indication, cancer segment was predicted to show maximum market share in the year 2022.
- Based on End User, pharmaceutical & biotech segment is expected to hold significant market share by 2030.
- Based on Component segmentation, lentiviral promoter segment was the leading in 2022
- On the basis of region, North America was the leading revenue generator in 2022.
Lentiviral Vector Contract Development and Manufacturing Organizations Market- Segmentation Analysis:
The Global Lentiviral Vector Contract Development and Manufacturing Organizations Market is segmented on the basis of Component, Disease Indication, End User, and Region.
The market is divided into four categories based on Component: lentiviral promoter, lentiviral fusion tags, lentivirus packaging systems and others. The lentiviral promoter segment dominates the market. Increasing demand from medical sector for lentiviral contract developments is contributing to market growth.
The market is divided into five categories based on Disease Indication: cancer, genetic disorders, infectious diseases, veterinary disease, and others. The cancer segment dominates the market. Increasing prevalence of cancer and its other disease forms is expected to boost the market growth.
The market is divided into three categories based on End User: pharmaceutical & biotech, academic research, and others. The pharmaceutical & biotech segment dominates the market. The rising demand from medical development in pharma sector is increasing the segment growth.
Lentiviral Vector Contract Development and Manufacturing Organizations Market- Geographical Insights:
Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.
Lentiviral Vector Contract Development and Manufacturing Organizations Market- Competitive Landscape:
Owing to the fast development in medical, and rising demand from pharmaceutical sector, which influence the lentiviral vector contract development and manufacturing organizations market. Several companies promote their products, including corporate websites, and Disease Indications, are used by businesses to sell their solutions & Disease Indications. Composite manufacturers compete on various factors, such as composite pricing, performance, composite creation, and marketing. reputation, and availability. Some of the primary techniques, and strategies used by corporations to consolidate their reach and expand their market share include new product launches, R&D expenditure, developing its distribution network and mergers & acquisitions. Some of the recent developments are mentioned below.
Recent Developments:
In 2021, Oxford Biomedica signed a new three-year development and supply agreement with Boehringer Ingelheim to manufacture and supply viral vectors.
Key features of the study:
- This proposed research study on Lentiviral Vector Contract Development and Manufacturing Organizations market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year
- The report provides the client the latest up-to-date and trending insights about the Lentiviral Vector Contract Development and Manufacturing Organizations market.
- The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Lentiviral Vector Contract Development and Manufacturing Organizations market
- The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Lentiviral Vector Contract Development and Manufacturing Organizations market
- Impact of COVID-19 on Lentiviral Vector Contract Development and Manufacturing Organizations market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Lentiviral Vector Contract Development and Manufacturing Organizations market post-COVID will also be covered.
- In order to give the users of this report a comprehensive view on the Lentiviral Vector Contract Development and Manufacturing Organizations market, we have also included competitive landscape and key innovator analysis for the Lentiviral Vector Contract Development and Manufacturing Organizations market.
- The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
- The report offers detailed company profiling featuring major market participants which will help users to understand their financial inspection and strategic initiatives of players operating in the Lentiviral Vector Contract Development and Manufacturing Organizations market.
- In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
- The global Lentiviral Vector Contract Development and Manufacturing Organizations market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL LENTIVIRAL VECTOR CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS MARKET KEY PLAYERS
- Thermo Fisher Scientific Inc.
- Oxford Biomedica
- Charles River Laboratories International, Inc.
- Creative Biogene
- GenScript ProBio
- Merck KGaA
- Catalent Inc.
- Ask Bio
- Lonza
- Curia Global, Inc.
- Wuxi Advanced Therapies
- SIRION Biotech GmbH
- VGXI, Inc.
- Yposkesi
- Oxford Genetics Ltd.
GLOBAL LENTIVIRAL VECTOR CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS MARKET, BY COMPONENT
- Lentiviral promoter
- Lentiviral fusion tags
- Lentivirus packaging systems
- Others
GLOBAL LENTIVIRAL VECTOR CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS MARKET, BY DISEASE INDICATION
- Cancer
- Genetic disorders
- Infectious diseases
- Veterinary disease
- Others
GLOBAL LENTIVIRAL VECTOR CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS MARKET, BY END USER
- Pharmaceutical & biotech
- Academic research
- Others
GLOBAL LENTIVIRAL VECTOR CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA